On the morning of Wednesday, September 4, 2024, Hackensack Meridian Hackensack University Medical Center became the first hospital in the world to treat patients with Aquablation® therapy using the new HYDROS™ Robotic System.
Mount Sinai Health System today announced that they will be among the first in the world to deploy blood-based biomarkers (blood tests) and confirmatory tests for Alzheimer’s disease and related dementias to patients across primary and specialty care settings—early detection tools that have never before been offered to patients in the clinical setting—as part of the Davos Alzheimer’s Collaborative (DAC) Healthcare System Preparedness Accurate Diagnosis project.
Personas con una sobreabundancia de glóbulos blancos clonados, o linfocitos, que dañan su sistema inmunológico, una afección llamada linfocitosis monoclonal de células B (LMB), pueden tener un riesgo elevado de desarrollar diversas complicaciones de salud, incluido el melanoma, una forma de cáncer de piel.
Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease.
Democratic vice presidential candidate Tim Walz and his son, Gus, went viral when Gus was seen celebrating his dad’s acceptance speech at the DNC. ...
Children who faced food insecurity during early childhood—or whose mothers experienced it during pregnancy—had a higher body mass index (BMI) and more than 50% increased chance of developing obesity or severe obesity in childhood and adolescence, according to a new study funded by the NIH Environmental influences on Child Health Outcomes (ECHO) Program.
In 2022, a team from Children’s Hospital Los Angeles became the first in the world to implant a novel cardiac stent designed specifically for babies and young children. The stent is the first of its kind that can be expanded as a child grows—all the way to adult size.
AANA announced the creation of a new membership category for registered nurses and advanced practice registered nurses.
A new study from researchers at Wake Forest University School of Medicine shows that inpatient food insecurity, experienced by caregivers during their child’s hospitalization, is associated with not only longer hospital admissions but also significantly increased odds of readmission.
A new survey from the American Academy of Sleep Medicine reveals that nearly half (45%) of parents have given melatonin to a child under the age of 18 to help him or her sleep.
WashU Medicine scientists lead two large, multicenter programs to develop vaccines and antibody-based therapies for understudied viruses with pandemic potential. The programs are supported by two grants from the National Institute for Allergy and Infectious Diseases (NIAID) totaling more than $30 million a year for three years.
September is National Sickle Cell Awareness Month. Experts from Johns Hopkins Medicine who specialize in sickle cell disease are available to discuss health equity issues related to sickle cell disease.
The latest research and advances in otolaryngology-head and neck surgery will be presented during the AAO-HNSF 2024 Annual Meeting & OTO EXPOSM in Miami, Florida, September 28 – October 1.
Award supports the development of a cell-based assay platform to help scientists discover and test drug candidates for liver fibrosis.
The National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) has announced the new Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders. Xingxing Zang, Ph.D., an international leader in developing novel immunotherapies, has been named its inaugural director.
Hackensack Meridian Mountainside Medical Center is honored to announce its selection as a site for the groundbreaking STEMI-DTU Clinical Trial.
Multiyear study finds that high levels of toxic metals in urine lead to high blood sugar
Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the CLEANER Vac™ Thrombectomy System for the removal of blood clot from the peripheral venous vasculature.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right